Tuesday, August 16, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Havana, Apr 5 (Prensa Latina) Cuba's anti-Covid-19 vaccine candidates Soberana 02 and Abdala (CIGB-66) enter on Monday in the administration of the second dose in Phase III of clinical trials, each day closer to demonstrating their response capacity to fight SARS-Cov-2.